ARQT vs PTC · rev $235.3M vs P/E 48, rev $2.74B
Arcutis Biotherapeutics Inc (ARQT) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
ARQT currently screens at market cap $1.64B. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the ARQT and PTC stock pages for the full models.
Not investment advice.